Á lódáil...
Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis
BACKGROUND: Interferons‐beta (IFNs‐beta) and glatiramer acetate (GA) were the first two disease‐modifying therapies (DMTs) approved 20 years ago for the treatment of multiple sclerosis (MS). DMTs' prescription rates as first or switching therapies and their costs have both increased substantial...
Na minha lista:
| Foilsithe in: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley & Sons, Ltd
2016
|
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464642/ https://ncbi.nlm.nih.gov/pubmed/27880972 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD009333.pub3 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|